Scintipharma   Report issue

For profit Phase 1
Founded: Lexington KY United States (1991)

Organization Overview

First Clinical Trial
2013
NCT01761123
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now